Approvals/TGA/ZOLGENSMA onasemnogene abeparvovec 2 x e13 vg/mL injection for intravenous infusion 5.5 mL vial

Approved

STANDARD

ZOLGENSMA onasemnogene abeparvovec 2 x e13 vg/mL injection for intravenous infusion 5.5 mL vial

Approval Id: b04e5fd8a1d2e3de
Product Name: ZOLGENSMA onasemnogene abeparvovec 2 x e13 vg/mL injection for intravenous infusion 5.5 mL vial
Artg Id: 327906
Artg Name: ZOLGENSMA onasemnogene abeparvovec 2 x e13 vg/mL injection for intravenous infusion 5.5 mL vial
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2021-03-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/898911bfb53dd716bb4a79f5cf8c3232.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e0b112ac040918c266be557ff4a7bead.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b04e5fd8a1d2e3de

Type

Standard